Ruling Against Johnson & Johnson Unit Affirmed

Law360, New York (June 16, 2006, 12:00 AM EDT) -- In the latest development in a long-running battle over the multi-billion dollar market for drug-coated coronary stents, a federal judge in Delaware has affirmed a jury’s decision that a stent made by Cordis Corp. infringes on a patent held by Boston Scientific Corp.

Cordis—a subsidiary of Johnson & Johnson—will appeal U.S. District Judge Sue Robinson’s ruling.

In an order dated June 15, Judge Robinson struck down a motion on behalf of Cordis Corp. that sought judgment as a matter of law or a new trial on...
To view the full article, register now.